The expression of MAPK, NF-κB, and AGER1 in the liver was significantly lower in the DL-arginine-treated STZ-induced T2DM rats than in the STZ-induced T2DM rats (p < 0.05) (Figure 12A). The gene discussed is DDOST; the disease is type 2 diabetes mellitus.